In the published article, there was an error. The genotypes used in the study were imputed to 1000 Genomes v1.3, not to Haplotype Reference Consortium (HRC) panel (pre-release 2015) as stated.
A correction has been made to Methods, Avon longitudinal study of parents and children population cohort, paragraph number three. This sentence previously stated:
“These data were jointly phased using SHAPEIT2 (Delaneau et al., 2013), which uses relationship information to improve phasing accuracy, and imputed to the Haplotype Reference Consortium (HRC) panel (pre-release 2015)”.
The corrected sentence appears below:
“These data were jointly phased using SHAPEIT2 (Delaneau et al., 2013), which uses relationship information to improve phasing accuracy, and imputed to the 1,000 Genomes v1.3.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
- Delaneau O., Zagury J., Marchini J. (2013). Improved whole-chromosome phasing for disease and population genetic studies. Nat. Methods 10, 5–6. 10.1038/nmeth.2307 [DOI] [PubMed] [Google Scholar]